Anika To Participate in 43rd Annual J.P. Morgan Healthcare Conference
23 déc. 2024 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Dec. 23, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that Dr. Cheryl...
Anika To Participate in December 2024 Investor Conferences
22 nov. 2024 16h16 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Nov. 22, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that senior...
Anika Reports Third Quarter 2024 Financial Results
31 oct. 2024 07h05 HE
|
Anika Therapeutics Inc.
Updating 2024 fiscal year guidance to reflect announced changes to business strategy, including the sale of Arthrosurface and planned divestiture of Parcus Medical, and U.S. OA Pain Management...
Anika Announces Strategic Update of Business with Sale of Arthrosurface and Plan to Divest Parcus Medical
31 oct. 2024 07h00 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 31, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company focused on early intervention orthopedics, today announced the...
Anika Announces Third Quarter 2024 Results Conference Call Date
17 oct. 2024 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 17, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, announced today that it will issue...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
04 oct. 2024 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Oct. 04, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on October 1,...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
09 sept. 2024 16h45 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Sept. 09, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on September...
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
15 août 2024 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 15, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that on August 1,...
Anika Reports Second Quarter 2024 Financial Results
08 août 2024 16h05 HE
|
Anika Therapeutics Inc.
Expanded Regenerative Solutions portfolio with full market release of the Integrity™ Implant System, a hyaluronic acid (HA)-based scaffold for rotator cuff and other tendon repairs, generating...
Anika to Participate in the Sidoti Virtual Investor Conference
05 août 2024 16h01 HE
|
Anika Therapeutics Inc.
BEDFORD, Mass., Aug. 05, 2024 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global joint preservation company in early intervention orthopedics, today announced that management will...